The American College of Rheumatology (ACR) named Krembil Emeritus Scientist Dr. Murray Urowitz recipient of the 2017 Distinguished Clinical Investigator Award. This highly prestigious award is presented annually to a clinical investigator that has made exceptional contributions to the field of rheumatology.
Dr. Urowitz’s research is focused on the study of the autoimmune disease known as systemic lupus erythematosus, which is commonly referred to as lupus. He is responsible for establishing a key resource for clinicians and researchers—a database containing one of the largest stores of clinical data on lupus, with data from over 1200 patients. This resource has led to the creation of the Centre for Prognosis Studies in The Rheumatic Diseases, for which Dr. Urowitz serves as Co-Director along with Dr. Dafna Gladman.
His research program has enabled the establishment of new standardized approaches for measuring lupus outcomes, which are now used worldwide; and has helped shed light on aspects of the disease, including disease flares, the effects on pregnancy and hormone replacement therapy, as well as diseases that are linked to lupus, such as cancer, renal disease and atherosclerosis.
Dr. Urowitz will receive this award of distinction at the ACR Annual Meeting in San Diego on November 4, 2017. To see the other awardees, visit the ACR website.
Congratulations to Dr. Urowitz!